large volume spacer devices systemic effects high dose corticosteroids high doses inhaled corticosteroids suppression hypothalamo-pituitary-adrenal axis influence mode drug inhalation degree suppression clear Hypothalamo-pituitary-adrenal function measurement serum cortisol concentrations short tetracosactrin test hour urine free cortisol excretion adults asthma micrograms dipropionate daily dose aerosol patients hypothalamo-pituitary-adrenal suppression subnormal results tests patient abnormal insulin stress test response patients dose beclomethasone dipropionate ml spacer device Volumatic endocrine tests days weeks patients Comparison initial values spacing device increase median cortisol concentration nmol/l nmol/l post-tetracosactrin cortisol concentration nmol/l nmol/l hour urine free cortisol excretion nmol nmol rise serum cortisol concentration response change Evidence hypothalamo-pituitary-adrenal axis suppression present patients pronounced improvements function long term oral corticosteroids results uncontrolled study asthmatic patients high dose beclomethasone dipropionate adverse effects large volume spacer device 